Tag: HPV

HPV infections in women eradicated by AHCC, Japanese mushroom extract

Results of human pilot study presented at SIO meeting in Houston (October 29, 2014, Beaverton, OR) New research presented at the Society for Integrative Oncology (SIO) 11th International Conference in Houston, TX showed for the first time that it is possible to eliminate HPV infection in women using a readily available nutritional supplement, AHCC. The…

UTHealth research shows mushroom extract, AHCC, helpful in treating HPV

HOUSTON – (Oct. 28, 2014) – A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at The University of Texas Health Science Center at Houston (UTHealth) Medical School. The results were presented at the 11th International Conference of the Society for Integrative Oncology…

HPV improves survival for African-Americans with throat cancer

29 JUL 2012 DETROIT – Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers. According to their new study, HPV has a substantial impact on…

HPV eradicated by AHCC supplement, preclinical study suggests

These data suggest AHCC can eliminate HPV infections   Japanese mushroom extract active hexose correlated compound (AHCC) may have role in prevention HPV-related cancers (March 23, 2014, Beaverton, OR) Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro…

HPV-positive OPSCC patients nearly twice as likely to survive as HPV-negative patients

 – HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.   Scottsdale, Ariz., February 20, 2014—A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy…

Mandatory HPV vaccination is unwarranted and unwise

2008 study posted for filing Contact: Amy Molnar journalnews@bos.blackwellpublishing.net 201-748-8844 Wiley-Blackwell Article explores how mandate does not represent public health necessity Washington, D.C. – November 12, 2008 – The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the…

Higher anaphylaxis rates after HPV vaccination: ” significantly higher – 5 to 20 fold – than that identified in comparable school-based vaccination program”

2008 study posted for filing Contact: Kim Barnhardt kim.barnhardt@cma.ca 613-731-8610 x2224 Canadian Medical Association Journal Despite higher rates, HPV vaccine safe for use OTTAWA, ONTARIO, CANADA – The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher – 5 to 20 fold – than that identified in comparable school-based…

HPV improves survival for African-Americans with throat cancer

DETROIT – Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers. According to their new study, HPV has a substantial impact on overall survival in…